This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in this journal  Topic Collections  • Medical Ethics  • Neonatology and Infant Care  • Alert me on articles by topic

Lainie Friedman Ross, MD, PhD

Arch Pediatr Adolesc Med. 2007;161(6):616-617.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Simonen et al¹ found that 1 week after obtaining the results of genetic risk for type 1 diabetes in newborns, 55% of mothers and 37% of fathers of high-risk infants expressed modest worry. Although one really wants to know about risk over a lifetime and its effect on parent-child relationships,^2-3 the data are cause for concern. Recall that a diagnosis of high-risk genotype confers between a 3% and 7% risk of developing type 1 diabetes, which is "4 to 10 times higher than the background population but still rather small."¹ Further recall that there are no current preventive therapies.

In previous articles, I have argued that newborn screening for type 1 diabetes is unethical because there are real harms, and it is not clear that the benefits outweigh the risks.^4-5 This is particularly true because the children identified at high risk have a rather small . . . [Full Text of this Article]

AUTHOR INFORMATION

RELATED LETTER

Against Newborn Screening for Type 1 Diabetes—Reply
Olli Simell
Arch Pediatr Adolesc Med. 2007;161(6):617-618.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Parental Reactions to Information About Increased Genetic Risk of Type 1 Diabetes Mellitus in Infants
Paula Simonen, Tapio Korhonen, Tuula Simell, Päivi Keskinen, Maarit Kärkkäinen, Mikael Knip, Jorma Ilonen, and Olli Simell
Arch Pediatr Adolesc Med. 2006;160(11):1131-1136.
ABSTRACT | FULL TEXT